Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CellaVision ABCHIX:CEVIS 97 3-Year Dividend Growth Rate is 7.70% as of Jun. 2026, which is 47% below its 10-year median of 14.50. GuruFocus rates CHIX:CEVIS with a GF Score™ of 97/100 and a GF Value™ of kr187.28. The stock has 2 warning signs investors should review. Among 223 Medical Devices & Instruments companies, CellaVision AB ranks better than 53.81% on this metric.
The historical rank and industry rank for CellaVision AB's 3-Year Dividend Growth Rate or its related term are showing as below:
CHIX:CEVIs'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -20.6 Med: 14.5 Max: 55.4
Current: 7.7
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CellaVision AB was 55.40% per year. The lowest was -20.60% per year. And the median was 14.50% per year.
CHIX:CEVIs's 3-Year Dividend Growth Rate is ranked better than 53.81% of 223
companies
in the Medical Devices & Instruments industry
Industry Median: 5.6
vs CHIX:CEVIs: 7.70
During the past 12 months, CellaVision AB's average Dividends Per Share Growth Rate was 10.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 7.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of CellaVision AB was 0.60. The lowest was 0.14. And the median was 0.40.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
CellaVision AB Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
SEK 2.750000
2026-04-29
2026-04-30
2026-05-06
Cash Dividend
annually
SEK:SEK 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
CellaVision AB's Dividend Yield (%) for Today is calculated as
Current Share Price is kr160.20.
CellaVision AB's Dividends per Share for the trailing twelve months (TTM) ended in Today is kr2.75.
During the past 13 years, the highest Dividend Yield of CellaVision AB was 2.11%. The lowest was 0.00%. And the median was 0.93%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellaVision AB 3-Year Dividend Growth Rate Related Terms>
CHIX:CEVIS vs ABT, SYK, MDT: 3-Year Dividend Growth Rate Comparison
For the Medical Devices subindustry, CellaVision AB's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellaVision AB 3-Year Dividend Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where CellaVision AB's 3-Year Dividend Growth Rate falls into.
CellaVision AB 3-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 7.70% mean?
CellaVision AB (CHIX:CEVIS) has a 3-Year Dividend Growth Rate of 7.70% as of Jun. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on CellaVision AB and its competitors. This is 47% below median its historical median of 14.50. According to the industry distribution chart, CellaVision AB ranks #103 out of 223 companies in the Medical Devices & Instruments industry, placing it in the top 46.2%.
Is CellaVision AB's 3-Year Dividend Growth Rate too high?
CellaVision AB's current 3-Year Dividend Growth Rate of 7.70% is 47% below median its 10-year median of 14.50. The Medical Devices & Instruments industry median 3-Year Dividend Growth Rate is 5.60. CellaVision AB's value of 7.70% is 37.5% above this industry median. Based on the distribution chart, CellaVision AB ranks #103 out of 223 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CellaVision AB has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's 3-Year Dividend Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CellaVision AB ranks #103 out of 223 companies for 3-Year Dividend Growth Rate. This puts CellaVision AB in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 5.60. CellaVision AB's value of 7.70% is 37.5% above this benchmark. While the company's 10-year median is 14.50 vs. the industry median of 5.60, CellaVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Dividend Growth Rate among Medical Devices & Instruments companies is 5.60, based on 223 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CellaVision AB's current 3-Year Dividend Growth Rate of 7.70% is 37.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on CellaVision AB and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Dividend Growth Rate is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CellaVision AB's current 3-Year Dividend Growth Rate is 7.70%, which is 47% below median its own 10-year median of 14.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
CellaVision AB (CHIX:CEVIS) has a current 3-Year Dividend Growth Rate of 7.70%. The stock's GF Value™ is kr187.28, compared to a current price of kr160.20 — trading 14.5% below its estimated fair value. The current 3-Year Dividend Growth Rate is 7.70%, which is 47% below median its 10-year median of 14.50 and 37.5% above the Medical Devices & Instruments industry median of 5.60. CellaVision AB's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For CellaVision AB (CHIX:CEVIS), the current 3-Year Dividend Growth Rate is 7.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellaVision AB (CHIX:CEVIS) Overvalued in 2026?
Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued.
The current stock price of kr160.20 is trading 14.5% below its estimated GF Value™ of kr187.28.
Key valuation signals for CHIX:CEVIS:
3-Year Dividend Growth Rate: 7.70% (47% below median its 10-year median of 14.50)
GF Value™: kr187.28 vs. price of kr160.20 (14.5% below fair value)
Industry Position: 37.5% above the Medical Devices & Instruments median (#103 of 223)
No single metric tells the full story. See the CHIX:CEVIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
97GF Score
Get the complete analysis for CHIX:CEVIS
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CEVIS has been successfully added to your 
